D
Denny Sakkas
Researcher at Yale University
Publications - 243
Citations - 11440
Denny Sakkas is an academic researcher from Yale University. The author has contributed to research in topics: Sperm & Medicine. The author has an hindex of 55, co-authored 194 publications receiving 10014 citations.
Papers
More filters
Journal ArticleDOI
Sperm DNA fragmentation: mechanisms of origin, impact on reproductive outcome, and analysis
TL;DR: The mechanisms responsible for DNA fragmentation in human sperm, including those occurring during spermatogenesis and transport through the reproductive tract are reviewed, and how abnormal sperm could be dealt with by the oocyte and how sperm DNA abnormalities may interfere with normal embryo and fetal development are discussed.
Journal ArticleDOI
Origin of dna damage in ejaculated human spermatozoa
TL;DR: The possible origins of DNA damage in ejaculated human spermatozoa are discussed, how these spermutozoa arrive in the ejaculate of some men, and what consequences they may have if they succeed in their genetic project are discussed.
Journal ArticleDOI
Nature of DNA Damage in Ejaculated Human Spermatozoa and the Possible Involvement of Apoptosis
Denny Sakkas,Odette Moffatt,Gian Carlo Manicardi,Ewa Mariethoz,Nicoletta Tarozzi,Davide Bizzaro +5 more
TL;DR: It is proposed that the presence of DNA damage is not directly linked to an apoptotic process occurring in spermatozoa and arises due to problems in the nuclear remodeling process, and may be linked to defects in cytoplasmic remodeling during the later stages of spermatogenesis.
Journal ArticleDOI
Extent of nuclear DNA damage in ejaculated spermatozoa impacts on blastocyst development after in vitro fertilization.
TL;DR: The extent of nuclear DNA fragmentation in prepared ejaculated spermatozoa used in IVF negatively correlates with blastocyst development.
Journal ArticleDOI
Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial.
Santiago Munné,Brian Kaplan,John L. Frattarelli,Tim Child,Gary S. Nakhuda,F. Nicholas Shamma,Kaylen M. Silverberg,Tasha Kalista,Alan H. Handyside,Mandy G. Katz-Jaffe,Dagan Wells,Tony Gordon,Sharyn Stock-Myer,S.P. Willman,Brian D Acacio,Stuart Lavery,Anna Carby,Robert Boostanfar,Robert Forman,Mark Sedler,Anthea Jackson,Keith Jordan,William B. Schoolcraft,S. McReynolds,Vicki L. Schnell,Randall A. Loy,Samuel J. Chantilis,Lowell Ku,John L. Frattarelli,Arlene J. Morales,H. Randall Craig,Mark Perloe,Craig A. Witz,Wei-Hua Wang,J. Wilcox,J.M. Norian,Stephanie Marshall Thompson,Serena Chen,John Garrisi,Renee Walmsley,Robert J. Mendola,Samuel Pang,Denny Sakkas,Kristin L. Rooney,Rita Sneeringer,M.J. Glassner,Leeanda Wilton,Mirjana Martic,Peter Coleman,Stephanie Shepley,Ginny Mounce,Tracey Griffiths,Ronald F. Feinberg,Keith L. Blauer,Brett Reggio,Rachel Rhinehart,William F. Ziegler,Hina Ahmed,Scott Kratka,Evan M. Rosenbluth,K. Ivani,Angela C. Thyer,T. Minter,Charles M. Miller,Mathias Gysler,Pauline Saunders,Robert F. Casper,Deirdre A. Conway,Mark R. Hughes,Michael Large,Joshua Blazek,Elpida Fragouli,Samer Alfarawati +72 more
TL;DR: There was a significant increase in OPR per embryo transfer with the use of PGT-A in the subgroup of women aged 35-40 years who had two or more embryos that could be biopsied, but this was not significant when analyzed by ITT.